Efficacy of CilostAzol for Below-the-knee artery disease after Balloon AnGioplasty in patiEnts with severe limb ischemia

Efficacy of CilostAzol for Below-the-knee artery disease after Balloon AnGioplasty in patiEnts with severe limb ischemia - CABBAGE

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007910

Enrollment

100

Registered

2012-06-01

Start date

2012-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

critical limb ischemia

Interventions

cilostazol+aspirin aspirin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with critical limb ischemia (Rutherford 4-6)

Exclusion criteria

Exclusion criteria: conesteive heart failure bleeding tendency serum Creatinine >2.0mg/dl acute onset limb ischemia

Design outcomes

Primary

Measure	Time frame
angiographic restenosis	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026